agent: be effective in cancer treatment

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents biological agent
Weight: 0.76
, real estate agent
Weight: 0.65
, source
Weight: 0.64
, contractor
Weight: 0.62
Siblings travel agent
Weight: 0.75
, representative
Weight: 0.67
, beta blocker
Weight: 0.65
, solicitor
Weight: 0.63
, attorney
Weight: 0.62

Related properties

Property Similarity
be effective in cancer treatment 1.00
be effective as antianginal medications 0.81
be effective as medications 0.80
is effective 0.78
be given to heart attack patients 0.76
be important before surgery 0.75
be less effective in elderly 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.09
Rule weight: 0.13
Evidence weight: 0.92
Similarity weight: 0.76
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment) ⋁
Evidence: 0.20
¬ Remarkable(beta blocker, be given to heart attack patients)
0.08
Rule weight: 0.13
Evidence weight: 0.78
Similarity weight: 0.75
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment) ⋁
Evidence: 0.51
¬ Remarkable(beta blocker, be less effective in elderly)
0.07
Rule weight: 0.13
Evidence weight: 0.70
Similarity weight: 0.75
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment) ⋁
Evidence: 0.71
¬ Remarkable(beta blocker, be important before surgery)
0.07
Rule weight: 0.13
Evidence weight: 0.65
Similarity weight: 0.81
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment) ⋁
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications)
0.07
Rule weight: 0.13
Evidence weight: 0.66
Similarity weight: 0.78
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment) ⋁
Evidence: 0.79
¬ Remarkable(beta blocker, is effective)

Remarkability from sibling implausibility

0.48
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.81
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.83
Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.57
¬ Plausible(beta blocker, be effective as antianginal medications)
0.45
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.78
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.79
Remarkable(beta blocker, is effective) ⋁
Evidence: 0.82
¬ Plausible(beta blocker, is effective)
0.44
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.20
Remarkable(beta blocker, be given to heart attack patients) ⋁
Evidence: 0.25
¬ Plausible(beta blocker, be given to heart attack patients)
0.44
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.75
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.71
Remarkable(beta blocker, be important before surgery) ⋁
Evidence: 0.81
¬ Plausible(beta blocker, be important before surgery)
0.43
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.75
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.51
Remarkable(beta blocker, be less effective in elderly) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be less effective in elderly)

Salient implies Plausible

0.25
Rule weight: 0.28
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.85
¬ Salient(agent, be effective in cancer treatment)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.85
Salient(agent, be effective in cancer treatment) ⋁
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment) ⋁
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment)

Typical implies Plausible

0.41
Rule weight: 0.48
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.79
Similarity weight: 0.81
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment) ⋁
Evidence: 0.50
¬ Typical(beta blocker, be effective as antianginal medications)
0.08
Rule weight: 0.14
Evidence weight: 0.79
Similarity weight: 0.76
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment) ⋁
Evidence: 0.49
¬ Typical(beta blocker, be given to heart attack patients)
0.07
Rule weight: 0.14
Evidence weight: 0.66
Similarity weight: 0.78
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment) ⋁
Evidence: 0.80
¬ Typical(beta blocker, is effective)
0.07
Rule weight: 0.14
Evidence weight: 0.65
Similarity weight: 0.75
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment) ⋁
Evidence: 0.83
¬ Typical(beta blocker, be important before surgery)
0.06
Rule weight: 0.14
Evidence weight: 0.64
Similarity weight: 0.75
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment) ⋁
Evidence: 0.86
¬ Typical(beta blocker, be less effective in elderly)